Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia
Open Access
- 1 May 2016
- journal article
- Published by Canadian Science Publishing in Journal of Psychiatry and Neuroscience
- Vol. 41 (3) , E46-E55
Abstract
Background: Alterations in the innate immune/inflammatory system may underlie the pathophysiology of schizophrenia, but we do not understand the mechanisms involved. The main agents of innate immunity are the Toll-like receptors (TLRs), which detect molecular patterns associated with damage and pathogens. The TLR first reported was TLR4, and it is still the most studied one. Methods: We aimed to describe putative modifications to the TLR4 proinflammatory pathway using 2 different strategies in 2 cohorts of patients with schizophrenia and matched controls: 1) quantification of protein and mRNA expression in postmortem prefrontal cortex samples from 30 patients with schizophrenia and 30 controls, and 2) identification of single nucleotide polymorphisms associated with the risk of schizophrenia using whole blood samples from 214 patients with schizophrenia and 216 controls. Results: We found evidence of alterations in the expression of the initial elements of the TLR4 signalling pathway (TLR4, Myeloid differentiation primary response gene 88 [MyD88] and nuclear factor-κ B [NF-κB]) in the PFC of patients with schizophrenia. These alterations seem to depend on the presence/absence of antipsychotic treatment at death. Moreover, a polymorphism within the MyD88 gene was significantly associated with schizophrenia risk. Limitations: The use of 2 different approaches in 2 different cohorts, the lack of a complementary neuropsychiatric group, the possible confounding effects of antipsychotic treatment and suicide are the main limitations of our study. Conclusion: The evidence from this dual approach suggests there is an altered innate immune response in patients with chronic schizophrenia in which the TLR4 proinflammatory pathway could be affected. Improved understanding of the stimuli and mechanisms responsible for this response could lead to improved schizophrenia treatment and better control of the side effects of current antipsychotics.Keywords
This publication has 63 references indexed in Scilit:
- The impact of single and pairwise Toll-like receptor activation on neuroinflammation and neurodegenerationJournal of Neuroinflammation, 2014
- The *1244 A>G polymorphism of MyD88 (rs7744) is closely associated with susceptibility to ulcerative colitisMolecular Medicine Reports, 2013
- Genome-wide association analysis identifies 13 new risk loci for schizophreniaNature Genetics, 2013
- Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammationInternational Journal of Neuropsychopharmacology, 2013
- Toll-like receptor signaling in neural plasticity and diseaseTrends in Neurosciences, 2011
- Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NFκB signalling pathwaysAnnals of the Rheumatic Diseases, 2010
- The Impact of Heat Shock Protein 70 Gene Variations on Clinical Presentation and Outcome in Schizophrenic InpatientsNeuropsychobiology, 2009
- Long-term antipsychotic treatments and crossover studies in rats: Differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brainJournal of Psychiatric Research, 2007
- Stress-Induced Oxidative Changes in BrainCNS & Neurological Disorders - Drug Targets, 2006
- Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: SchizophreniaThe American Journal of Human Genetics, 2003